advertisement

---

Ishida K 8

Showing records 1 to 8 | Display all abstracts from Ishida K

61754 Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Inoue K
Clinical Ophthalmology 2015; 9: 619-623

---

61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Inuzuka H
Journal of Glaucoma 2016; 25: e591-e595

---

61754 Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Shiokawa M
Clinical Ophthalmology 2015; 9: 619-623

---

61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Kawase K
Journal of Glaucoma 2016; 25: e591-e595

---

61754 Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Ishida K
Clinical Ophthalmology 2015; 9: 619-623

---

61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Sawada A; Kokuzawa S
Journal of Glaucoma 2016; 25: e591-e595

---

61754 Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Tomita G
Clinical Ophthalmology 2015; 9: 619-623

---

61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Ishida K; Yamamoto T
Journal of Glaucoma 2016; 25: e591-e595

---